.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Remedi's performance in the Illinois market showcases notable movements across different product categories. In the Concentrates category, Remedi experienced a positive trend, improving its ranking from 24th in January 2026 to 18th by March 2026, indicating a strengthening position within the state. This upward movement is supported by a significant increase in sales, which more than doubled from February to March 2026. Conversely, in the Tincture & Sublingual category, Remedi maintained a consistent ranking in third place throughout the observed months, suggesting a stable consumer base and a strong foothold in this particular segment. However, the sales figures for March 2026 showed a decline, which might be an area of concern if the trend continues.
In Massachusetts, Remedi's performance in the Concentrates category is less favorable. The brand's ranking fell from 29th in January 2026 to 55th by March 2026, indicating a loss of market presence and possibly facing increased competition or changing consumer preferences. This decline in ranking is mirrored by a substantial decrease in sales during the same period. Notably, Remedi did not appear in the top 30 brands in Massachusetts by February and March 2026, highlighting a significant challenge in maintaining relevance in this market. This suggests that Remedi might need to reassess its strategies in Massachusetts to regain traction and improve its market position.
Competitive Landscape
In the Illinois concentrates market, Remedi has shown a notable improvement in its ranking from December 2025 to March 2026, climbing from 20th to 18th place. This upward trend is significant given the competitive landscape. For instance, UpNorth Humboldt experienced a decline, dropping from 15th to 17th, while Legacy Cannabis (IL) maintained a more stable position, slightly improving from 19th to 16th. Meanwhile, Redemption Botanicals saw a decline from 13th to 19th, which could have contributed to Remedi's rise. Although Nature's Heritage entered the top 20 in February 2026, it remained at the lower end of the rankings. Remedi's sales also saw a significant increase in March 2026, nearly doubling from January, suggesting a positive reception in the market and potential for further growth.
Notable Products
In March 2026, the Indica Relief RSO Syringe (0.5g) maintained its top position in the Remedi product lineup, with sales reaching 1978 units. The Indica Rest RSO Dropper (0.5g) held steady at rank 2, showing a notable increase in sales compared to February. The Indica Rest RSO Syringe (0.5g) moved down to rank 3 after a brief rise to rank 2 in February. The CBD/THC 1:5 Rest Tincture remained at rank 4, although its sales figures decreased from the previous month. Lastly, the CBD/THC 1:1 Relief Tincture consistently held the fifth position since January, despite a gradual decline in sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
